Trially® is the first AI-native platform that matches, engages & enrolls patients with ~95% accuracy at breakthrough speed.
Trially has raised $4.7M in total funding. The most recent round was Seed. The last funding was announced in September 2025.
Trially's investors include Gaingels, Flyover Capital, Alpaca, Blu Venture Investors, Redbud VC.
Trially is headquartered in Kansas City, United States.
Trially® is the first AI-native platform that matches, engages & enrolls patients with ~95% accuracy at breakthrough speed.
Trially is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Trially — Funding & Investors." VCBacked, September 16, 2025, https://www.vcbacked.co/company/trially. Accessed August 14, 2026.
VCBacked. (2025). Trially — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/trially
{{cite web |title=Trially — Funding & Investors |url=https://www.vcbacked.co/company/trially |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated